Pharmadrug (FRA:G11) Debt-to-Asset : 1.83 (As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Pharmadrug Debt-to-Asset?

Pharmadrug's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €0.93 Mil. Pharmadrug's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €0.00 Mil. Pharmadrug's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was €0.51 Mil. Pharmadrug's debt to asset for the quarter that ended in Sep. 2024 was 1.83.

Pharmadrug Debt-to-Asset Historical Data

The historical data trend for Pharmadrug's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmadrug Debt-to-Asset Chart

Pharmadrug Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.30

0.08

0.04

0.12

1.47

Pharmadrug Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.13	1.47	1.34	1.59	1.83

Competitive Comparison of Pharmadrug's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmadrug's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmadrug's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmadrug's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Pharmadrug's Debt-to-Asset falls into.

Pharmadrug Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Pharmadrug's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.208	+	0)	/	0.82
	=	1.47

Pharmadrug's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.933	+	0)	/	0.509
	=	1.83

Pharmadrug (FRA:G11) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Pharmadrug Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Pharmadrug's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmadrug Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmadrug Inc (FRA:G11) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

LMLLF:USA PHRX:Canada

Address

77 King Street West, Suite 2905, Toronto, ON, CAN, M5K 1H1

Website

https://www.pharmadrug.ca

Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The Company's operations comprise of the corporate division in Canada. Geographically, it operates in Germany and Canada.

Pharmadrug Headlines

No Headlines